Age-multiplied low density lipoprotein cholesterol (LDL-C) burden (AM-LDL) index stratifies bleeding and ischemic risk in acute coronary syndrome: implications for early therapeutic intensification

The AM-LDL index, derived from two readily available admission parameters, is associated with post-discharge one-year MACE and NACE risks among ACS patients. Its application may help improve risk stratification, allowing for timely treatment intensification and a more personalized prevention strategy, while warranting validation in interventional trials before clinical implementation.